Robert Chang

Robert Chang is an Analyst at Vida Ventures, a dedicated life sciences venture capital firm operating across offices in Boston, Los Angeles, and San Francisco. In this capacity, he supports the firm's broader investment strategy and capital deployment across a biomedical portfolio backed by approximately $1.8 billion in total assets under management. Working alongside firm leadership, including Co-Founder and Senior Managing Director Fred Cohen, Chang evaluates early-stage biomedical innovations, clinical-stage therapeutics, and novel drug discovery platforms. His specific sector coverage encompasses emerging therapeutic modalities, primarily targeting advancements in genetic medicines, complex cell engineering, and other advanced biotechnology applications within the broader healthcare market. Chang currently focuses on sourcing, conducting technical due diligence, and analyzing prospective life sciences investments to help fund and build biotechnology companies driven by rigorous scientific expertise and clinical potential.